Comparison of Memory Function and MMPI-2 Profile Between Post-Traumatic Stress Disorder and Adjustment Disorder After a Traffic Accident
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Monosymptomatic Hypochondriacal Psychosis (Somatic Delusional Disorder): a Report of Two Cases
SCIENTIFIC LETTER | http://dx.doi.org/10.4314/ajpsy.v16i2.11 Afr J Psychiatry 2013;16:87-91 Monosymptomatic Hypochondriacal Psychosis (somatic delusional disorder): A report of two cases Historically, the term Monosymptomatic Hypochondriacal abusing any psychoactive substances and was said to be well Psychosis (MHP) was first used by Munro in 1978. 1 MHP is adjusted premorbidly. Based on history and examination, she classified as a somatic type of delusional disorder in DSM- IV 2 was managed as a case of paranoid schizophrenia (with and is defined as an erroneous conviction of bodily disease, olfactory reference syndrome) and was treated with abnormality or alteration. 3 It includes delusional beliefs about haloperidol 15mg daily to which she responded positively bodily sensations or functions; such as feeling malodorous, after one week. As of when she was seen last in the out-patient being infected by parasites, having dysmorphic features, or clinic, she remained stable on maintenance dose of that a certain organ is no longer functioning. 4 MHP has been haloperidol 5mg nocte. divided into 4 main categories: Delusions of infestation Mr B was a 45 year old married, Christian saw-miller who (including parasitosis); delusions of dysmorphophobia, such presented with a year and a half history of the feeling that as of misshapenness, personal ugliness, or exaggerated size insects were crawling all over his body, a mucus substance of body parts (this seems closest to that of body dysmorphic entering his eyes and a three month history of inadequate disorder); delusions of foul body odours or halitosis or sleep. The insects were of different sizes and shapes (cubiodal delusional bromosis (also known as olfactory reference and cylindrical). -
Obsessive Compulsive Disorder with Associated Hypochondriasis
PRACTICE BMJ: first published as 10.1136/bmj.39555.608252.AD on 8 May 2008. Downloaded from A PATIENT’S JOURNEY Obsessive compulsive disorder with associated hypochondriasis Pamela Harrington So how did it all start? North Nesting, Pamela Harrington developed obsessive ’ “ ” Armathwaite CA4 9PB compulsive disorder with associated I ll begin by describing the critical incident that I [email protected] believe triggered the clinical phase of my obsessive hypochondriasis 24 years ago. Eventually, compulsive disorder. BMJ 2008;336:1070-1 doi:10.1136/bmj.39555.608252.AD a sympathetic and patient general I was 24 years old (I am 48 now) and my mum needed practitioner enabled her to manage her open heart surgery. We were all afraid she would die, but nobody said so. Instead of supporting each other, condition we fought each other. I was trying to cope and to stop the fighting, especially between my sister and my father I’ve seen it in their eyes. “Oh, God, not her again. I’ve and brother. The day of mum’s operation, the tension got a waiting room full of patients and she’s back. I exploded and I had a massive row with my sister. I wonder what it is this time. I’ve told her a thousand completely “lost it” and was left sobbing uncontrol- times there’s nothing wrong with her. Why doesn’t she lably. The next morning I was getting ready to go to the trust me? I’m the doctor. What does she know? Been hospital when this thought flew through my head, looking stuff up on the internet again, I suppose.” “Maybe it would be easier if she died.” If only he would look into my eyes. -
Case Report Treatment of Hypochondriasis in Two Schizophrenia Patients Using Clozapine
Hindawi Case Reports in Psychiatry Volume 2017, Article ID 5064047, 3 pages https://doi.org/10.1155/2017/5064047 Case Report Treatment of Hypochondriasis in Two Schizophrenia Patients Using Clozapine Antonio Tundo, Luca Proietti, and Rocco de Filippis Istituto di Psicopatologia, Via Girolamo da Carpi 1, 00196 Rome, Italy Correspondence should be addressed to Antonio Tundo; [email protected] Received 14 February 2017; Revised 24 April 2017; Accepted 2 May 2017; Published 31 May 2017 Academic Editor: Douglas L. Noordsy Copyright © 2017 Antonio Tundo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Hypochondriasis (HYPO), an obsessive-compulsive spectrum disorder, is frequent in patients with schizophrenia (SCH) (20%), especially among those treated with clozapine (36.7%). Treatment options for OCS/OCD in patients under clozapine (CLZ) include combining clozapine with amisulpride/aripiprazole or a mood stabilizer, augmenting clozapine with a serotoninergic reuptake inhibitor, adding cognitive behavioural therapy, and gradually reducing dosage. No treatments have been proposed for HYPO in patients using clozapine so we examine these options in 2 cases and report the results. Among treatments delivered, only dosage reduction adequately worked. We recommend caution when thinking about escalating treatment and suggest trying it only when alternative interventions were not successful and weighing risk and benefits of this therapeutic strategy. Further research is needed to confirm the hypothesis that CLZ treatment induces hypochondriac symptoms, to investigate the prevalence of the phenomenon, and, mostly, to identify possible treatment strategies. -
Anxiety in Children and Adolescents with Autism Spectrum Disorders
Research in Autism Spectrum Disorders 3 (2009) 1–21 Contents lists available at ScienceDirect Research in Autism Spectrum Disorders Journal homepage: http://ees.elsevier.com/RASD/default.asp Review Anxiety in children and adolescents with Autism Spectrum Disorders Bonnie M. MacNeil *, Vicki A. Lopes, Patricia M. Minnes Queen’s University, Kingston, Ontario, Canada ARTICLE INFO ABSTRACT Article history: Anxiety symptoms and disorders are highly prevalent in children Received 29 February 2008 and adolescents with Autism Spectrum Disorder (ASD), although Received in revised form 29 May 2008 they are often unrecognized or misdiagnosed. The purpose of the Accepted 6 June 2008 present review is to (1) provide clinicians with practical informa- tion on assessment and diagnosis of co-morbid anxiety in children Keywords: and adolescents with ASD, (2) summarize and critically examine the Anxiety literature on anxiety in children and adolescents with ASD, and (3) ASD recommend avenues for future research in this area. A review of the Prevalence literature yielded several recommendations for the assessment of Assessment anxiety in youth with ASD. It was concluded that comprehensive assessments of anxiety in ASD populations should use multiple informants, multimodal assessment techniques, and standardized assessment methods that are appropriate for clinical use in ASD samples. Overall, studies suggest that youth with ASD experience greater levels of anxiety than community populations, similar levels of anxiety to clinically anxious groups, and different patterns of anxiety when compared to other clinical groups. Although existing studies are methodologically fair, their correspondence with clinical recommendations for assessment is poor. Recommenda- tions to improve of the quality of empirical studies and directions for future research are discussed. -
Health Anxiety and Hypochondriasis in the Light of DSM-5 Josef Bailera*, Tobias Kerstner A, Michael Witthöft B, Carsten Diener C,D , Daniela Mier a and Fred Rist E
Erschienen in: Anxiety, Stress, & Coping ; 29 (2016), 2. - S. 219-239 https://dx.doi.org/10.1080/10615806.2015.1036243 Health anxiety and hypochondriasis in the light of DSM-5 Josef Bailera*, Tobias Kerstner a, Michael Witthöft b, Carsten Diener c,d , Daniela Mier a and Fred Rist e aDepartment of Clinical Psychology, Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany; bDepartment of Clinical Psychology, Johannes Gutenberg University, Mainz, Germany; cSchool of Applied Psychology, SRH University of Applied Sciences, Heidelberg, Germany; dDepartment of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany; eDepartment of Clinical Psychology, University of Münster, Münster, Germany Background: In the DSM-5, the diagnosis of hypochondriasis was replaced by two new diagnositic entities: somatic symptom disorder (SSD) and illness anxiety disorder (IAD). Both diagnoses share high health anxiety as a common criterion, but additonal somatic symptoms are only required for SSD but not IAD. Design: Our aim was to provide empirical evidence for the validity of these new diagnoses using data from a case–control study of highly health-anxious ( n = 96), depressed ( n = 52), and healthy (n = 52) individuals. Results: The individuals originally diagnosed as DSM-IV hypochondriasis predominantly met criteria for SSD (74%) and rarely for IAD (26%). Individuals with SSD were more impaired, had more often comorbid panic and generalized anxiety disorders, and had more medical consultations as those with IAD. Yet, no significant differences were found between SSD and IAD with regard to levels of health anxiety, other hypochondriacial characteristics, illness behavior, somatic symptom attributions, and physical concerns, whereas both groups differed signifi- cantly from clinical and healthy controls in all of these variables. -
Hypochondriasis and Disease-Claiming Behaviour in Generalpractice A
PERSONAL EXPERIENCE Hypochondriasis and disease-claiming behaviour in generalpractice A. R. DEWSBURY, M.R.C.G.P., D.P.M. Birmingham Problems of definition Hypochondriasis presents as a frequent problem in general practice. There is a need both to exclude physical illness and to protect the patient from unnecessary and expensive referrals and investigations. The hypochondriac is also prone to invoke anger in the physician as the patient continues to complain, refuses to accept reassurance or acts aggressively. Both anger and undue sympathy interfere with objective treatment. The hypochondriac is a problem for the taxonomist. The term was coined to describe patients with abdominal symptoms accompanied by mood disturbance (Gillespie, 1929). However the term is now more commonly used to describe patients presenting a bodily complaint for which no adequate physical cause can be found (Brown, 1936). For some authors hypo¬ chondriasis can be equated with depression (Kenyon, 1964). Others stress a multiplicity of complaints (Ray and Advanti, 1962), so that their patients resemble hysteria (in the sense defined by Guze and Perley in 1963). Thus Richards (1940) talks of hypochondriasis as a simple or diffuse eruption of somatic complaints. In order to study hypochondriasis appearing in general practice, attention was paid to what Pilowsky (1969) called "abnormal illness behaviour". In this category it was possible to include simultaneously: (1) those with sensations mimicking physical disease (sensohypochondriacs of Leonhard, 1961), (2) those convinced, without foundation, of specific physical illness (ideohypochondriacs), (3) those claiming illness, without the physician being sure that the patient had either of the above experiences (malingering). This avoids the need to conjecture as to the contents of the patient's consciousness as well as certain semantic difficulties. -
Bipolar Disorder
Unpacking Bipolar Disorder David C. Hall, MD Child Adolescent & Family Psychiatry Samaritan Center of Puget Sound February 8, 2011 Bipolar Disorders: Scope of the Problem ■ Bipolar I and II disorders occur in up to 4% of the population 1,2 ■ frequently begin in the mid to late-teens 3,4 ■ cause chronic disability 5-7 ■ characterized by recurrent and chronic symptoms with associated multiple psychiatric and medical comorbid conditions 1,2 ■ also excess and premature mortality and suicide 8-10 ■ Bipolar disorder has been listed among the top 10 causes of disability worldwide 7 ■ estimated to cost about $70 billion/year in 2008 dollars 11,12,15 Bipolar Disorders: Part I Understanding Diagnosis Whatever goes up must come down unless it goes into orbit Understanding the DSM Diagnostic and Statistical Manual, 4th Edition, Revised Published by the American Psychiatric Association ■ Committee determined symptom criteria ■ Based on peer reviewed literature and/or ■ Expert consensus ■ Disability or clear change from baseline lasting a week or more ■ Not accounted for by a broader category of illness or substance use ■ Designed to promote inter-rater consistency and credible research comparisons Bipolar Disorder: What is it? ■ A spectrum disorder of mood and cognition that has been described for centuries ■ Classification and treatments have developed mostly since the 1970’s ■ Psychotic levels of mania were often described as schizophrenia before then Diagnostic requirements ■ Symptoms meet full criteria for either ■ a major depressive episode in -
The ICD-10 Classification of Mental and Behavioural Disorders
The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines World Health Organization -1- Preface In the early 1960s, the Mental Health Programme of the World Health Organization (WHO) became actively engaged in a programme aiming to improve the diagnosis and classification of mental disorders. At that time, WHO convened a series of meetings to review knowledge, actively involving representatives of different disciplines, various schools of thought in psychiatry, and all parts of the world in the programme. It stimulated and conducted research on criteria for classification and for reliability of diagnosis, and produced and promulgated procedures for joint rating of videotaped interviews and other useful research methods. Numerous proposals to improve the classification of mental disorders resulted from the extensive consultation process, and these were used in drafting the Eighth Revision of the International Classification of Diseases (ICD-8). A glossary defining each category of mental disorder in ICD-8 was also developed. The programme activities also resulted in the establishment of a network of individuals and centres who continued to work on issues related to the improvement of psychiatric classification (1, 2). The 1970s saw further growth of interest in improving psychiatric classification worldwide. Expansion of international contacts, the undertaking of several international collaborative studies, and the availability of new treatments all contributed to this trend. Several national psychiatric bodies encouraged the development of specific criteria for classification in order to improve diagnostic reliability. In particular, the American Psychiatric Association developed and promulgated its Third Revision of the Diagnostic and Statistical Manual, which incorporated operational criteria into its classification system. -
Hypochondriasis: Considerations for ICD-11 Odile A
Revista Brasileira de Psiquiatria. 2014;36:S21–S27 ß 2014 Associac¸a˜ o Brasileira de Psiquiatria doi:10.1590/1516-4446-2013-1218 UPDATE ARTICLE Hypochondriasis: considerations for ICD-11 Odile A. van den Heuvel,1,2 David Veale,3,4 Dan J. Stein5 1Department of Psychiatry, VU University Medical Center (VUmc), Amsterdam, The Netherlands. 2Department of Anatomy & Neurosciences, VUmc, Amsterdam, The Netherlands. 3Institute of Psychiatry, King’s College London, London, UK. 4Center for Anxiety Disorders and Trauma, South London and Maudsley NHS Foundation Trust, London, UK. 5Department of Psychiatry, University of Cape Town, Cape Town, South Africa. The World Health Organization (WHO) is currently revisiting the ICD. In the 10th version of the ICD, approved in 1990, hypochondriacal symptoms are described in the context of both the primary condition hypochondriacal disorder and as secondary symptoms within a range of other mental disorders. Expansion of the research base since 1990 makes a critical evaluation and revision of both the definition and classification of hypochondriacal disorder timely. This article addresses the considerations reviewed by members of the WHO ICD-11 Working Group on the Classification of Obsessive-Compulsive and Related Disorders in their proposal for the description and classification of hypochondriasis. The proposed revision emphasizes the phenomenological overlap with both anxiety disorders (e.g., fear, hypervigilance to bodily symptoms, and avoidance) and obsessive-compulsive and related disorders (e.g., preoccupation and repetitive behaviors) and the distinction from the somatoform disorders (presence of somatic symptom is not a critical characteristic). This revision aims to improve clinical utility by enabling better recognition and treatment of patients with hypochondriasis within the broad range of global health care settings. -
Cognitive Behavior Therapy for Hypochondriasis a Randomized Controlled Trial
ORIGINAL CONTRIBUTION Cognitive Behavior Therapy for Hypochondriasis A Randomized Controlled Trial Arthur J. Barsky, MD Context Hypochondriasis is a chronic, distressing, and disabling condition that is preva- David K. Ahern, PhD lent in ambulatory medical practice. Until recently, no specific treatment has been clearly demonstrated to be effective. YPOCHONDRIASIS IS DEFINED Objective To assess the efficacy of a cognitive behavior therapy (CBT) for hypo- as a persistent fear or belief chondriasis. that one has a serious, un- Design A randomized, usual care control group design, conducted between Sep- diagnosed medical illness. tember 1997 and November 2001. The individual primary care physician was the HOccurring in as many as 5% of medi- unit of randomization, and all patients clustered within each physician’s practice cal outpatients, it is a prevalent, dis- were assigned to the experimental treatment (individual CBT and a consultation let- abling, and chronic condition that has ter to the primary care physician) or to the control condition. Subjects were generally been refractory to psycho- assessed immediately before and 6 and 12 months after the completion of treat- logical and pharmacological treat- ment. ment and costly for the health care sys- Setting and Participants Participants were 80 patients from primary care prac- tem.1-6 Until recently, there was no tices and 107 volunteers responding to public announcements, all of whom exceeded empirically validated treatment for the a predetermined cutoff score on a hypochondriasis self-report questionnaire on 2 suc- hypochondriacal patient’s somatic cessive occasions. symptoms, belief in the presence of an Intervention A scripted, 6-session, individual CBT intervention was compared with undiagnosed disease, health-related medical care as usual. -
SPECTRUM DISORDER Evaluation and Eligibility Guidelines
2007 AUTISM SPECTRUM DISORDER Evaluation and Eligibility Guidelines • Presented by • St. Clair County Regional Educational Service Agency TABLE OF CONTENTS INTRODUCTION ......................................................................................................................................................... 1 INTRODUCTION TO AUTISM SPECTRUM DISORDER (ASD) ............................................................................ 1 What is Autism Spectrum Disorder (ASD)? ............................................................................................................. 1 Michigan’s Definition of Autism Spectrum Disorder ............................................................................................... 1 Explanation of Michigan Department of Education (MDE) ..................................................................................... 2 Discussion of IDEA Definition of Autism ................................................................................................................ 5 AUTISM SPECTRUM DISORDER ELIGIBILITY ..................................................................................................... 6 Flow Chart for Initial Referrals to Special Education ............................................................................................... 6 Flow Chart for Students Currently Receiving Services ............................................................................................ 7 PRE-REFERRAL PROCESS ....................................................................................................................................... -
Dissociative, Somatic, & Autism Disorders
DISSOCIATIVE, SOMATIC, & AUTISM DISORDERS AP PSYCHOLOGY- MS. FORSBERG developmental deficits that produce impairments NEURODEVELOPMENTAL of personal, social, academic, or occupational functioning. Attention Deficit Hyperactivity Disorder (ADHD • Impairing levels of inattention, disorganization and/or hyperactivity-impulsivity. Tourette’s • Multiple motor and one or more vocal tics. Autism Spectrum Disorder (ASD) • Persistent deficits in social communication and social interaction across multiple contexts. SYMPTOMS OF AUTISM SPECTRUM DISORDER (ASD) Social Impairment Must be present in early • Trouble engaging in social interaction childhood & limit everyday • Little eye contact functioning for diagnosis. • Difficulty with communication • Respond unusually when people show emotion 3 boys for every 1 girl • Difficulty understanding another’s point of view Repetitive/Ritualistic Behaviors • Body repetition (rocking, arm flapping, etc.) • Object repetition (feeling certain textures, flicking a rubber band, etc.)-usually because of sensory sensitivity or under-sensitive • Strong need for routines and consistency: may develop object/activity obsessions. POSSIBLE CAUSES (ETIOLOGY) OF ASD Genetic Factors • In identical twins, if one has ASD, the other twin also has ASD in nearly 9 out of 10 cases. • Gene Mutations Environmental Factors • Currently being researched • Possible factors: family medical conditions, parental age and other demographic factors, exposure to toxins, and complications during birth or pregnancy. TREATMENTS FOR ASD ABA – Applied